Announced Thu, 23 Apr · 09:46 IST

Zenotech Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/04/2026 ,inter alia, to consider and approve Audited Standalone Financial ....

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-4.3%1-day move
₹47.00
prior close
₹46.50
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.3-0.3-0.3-0.3-4.3-0.6-2.1-3.2-6.4-7.7-4.3-1.7-6.4-4.6
Up moveDown movePending
AI summary

Zenotech Laboratories Ltd has informed BSE about a scheduled Board of Directors meeting on April 29, 2026. The meeting agenda includes consideration and approval of Audited Standalone Financial Results. This is a standard meeting intimation filing and does not contain actual financial data or results. The page content appears truncated, cutting off mid-sentence after 'Financial'. No financial performance metrics, auditor opinions, or other details are available in this filing.

Likely market impact

This is a routine meeting notice indicating the company will announce its audited standalone financial results after April 29, 2026. Investors should await the actual results filing for any meaningful financial information or signals about company performance.